blood stem cell transplantation than after allo-BMT, resulting in less morbidity and mortality. 3,4 There are relatively little data about the reconstitution of lymphocyte subThe expression of CD45RA + and CD45RO + isoforms on T cells and the recovery of B lymphocytes and NK cells sets after PBSCT. 5 B cell reconstitution is severely compromised for months to years after allo-BMT, 6 especially in after autologous peripheral blood stem cell transplantation (PBSCT) were studied during the early period patients with chronic graft-versus-host disease (GVHD). 
Summary:
blood stem cell transplantation than after allo-BMT, resulting in less morbidity and mortality. 3, 4 There are relatively little data about the reconstitution of lymphocyte subThe expression of CD45RA + and CD45RO + isoforms on T cells and the recovery of B lymphocytes and NK cells sets after PBSCT. 5 B cell reconstitution is severely compromised for months to years after allo-BMT, 6 especially in after autologous peripheral blood stem cell transplantation (PBSCT) were studied during the early period patients with chronic graft-versus-host disease (GVHD). 7, 8 Roberts et al 9 and Ashihara et al 10 demonstrated in their following transplantation. The same panel of monoclonal antibodies was used to analyze the lymphocyte studies that the B lymphocyte regeneration is faster following PBSCT. So far, there is speculation that an increased subsets after allogeneic bone marrow transplantation (allo-BMT) and in cord blood. The CD4
+ subsets regennumber of lymphoid progenitor cells and hematopoietic progenitors in the graft may be the reason for the faster erated differently from the CD8 + isoforms and the CD4 + CD45RA + subset appears to be the only thymusrecovery.
There are data that demonstrate a recapitulation of B cell ontogeny after transplantation. Small et al showing the immature type of B lymphocytes early after transplantation, declining to a normal B cell marker profile seems to be no thymic influence on the regeneration of the immature CD8 +
CD45RA
+ subset. The regeneration in the second post-transplant year. Storek et al 12 showed that a second round of B cell ontogeny occurred in transof the CD4 + cells was markedly delayed, but was faster in the PBSCT recipients, mainly because of the faster plant recipients without chronic GVHD. Does a faster recovery of B lymphocytes after PBSCT imply a faster recovery of the mature CD4 + CD45RO + subset. The pattern of surface antigens on T lymphocytes after transrecapitulation of ontogeny following PBSCT than after allo-BMT without cGVHD? Or, does a different T lymphoplantation did not resemble the antigen pattern on cord blood cells. The CD19 + CD20 + cells recovered earlier in cyte regeneration after PBSCT influence the faster B cell recovery, since a lack of appropiate T cell support is proven the PBSCT group and remained compromised after allo-BMT during the time studied. The faster B lymphoto contribute to deficiencies of B cell function.
13-17
To date, the mechanisms of T cell regeneration are not cyte regeneration correlates with the faster reconstitution of the mature CD4 +
CD45RO
+ cells. The pattern completely understood. Both CD4 + and CD8 + human lymphocytes consist of functionally distinct subsets, based on of antigens CD38 + , HLA-DR + , CD10 + on B lymphocytes of the recovery phase resembled the pattern on B cells the expression of different isoforms of the CD45 antigen. At birth, most T cells express isoforms which are detected of cord blood lymphocytes. The NK cells were not deficient at any time post-transplant in both groups.
with CD45RA monoclonal antibodies. The CD45RO + isoforms increase thereafter to reach about 50% in adult life.
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The expression of CD45RO receptors characterizes a T cell as a mature cell of the memory type, responding to antigen stimulation, 19 whereas the CD45RA receptor-positive cells are considered to be immature and naive. They may convert Allogeneic bone marrow transplantation and peripheral to mature CD45RO + cells after stimulation. The expression blood stem cell transplantation have been proved to be of the CD45RO antigen, however, seems to be bidirectional effective therapies for patients with hematopoietic maligand may revert to the CD45RA + isoform. 18 nancies and a variety of solid tumors. 1 Intensive chemoThere is no evidence of recapitulation of ontogeny of T therapy with and without total body irradiation severely and cells post-transplant, but it appears that the thymus plays an irreversibly damages the bone marrow, which can be reconimportant role in T cell ontogeny. Anti-CD4 (Leu 3a) PerCP, anti-CD45RA FITC, anti-CD45RO PE were taken for T helper cell subclassification. Bone marrow was collected from the HLA-identical siblings from the posterior iliac crest, under general anas-CD8 cells were stained with anti-CD8 (Leu 2a) PerCP, anti-CD45RA FITC and anti-CD45RO PE for further subthesia. The leukaphereses were done on day 5 and 6 after the start of mobilization with G-CSF (filgrastim) 10 g/kg classification. CD19 + CD20 + B lymphocytes were further stained by the use of anti-CD10 (anti-calla) FITC, antidaily subcutanously. A mean of two leukaphereses was performed using the Cobe Spectra (Lakewood, CO, USA) con-HLA-DR PE, anti-CD38 (Leu 17) PE. Anti-CD14 (Leu M3) FITC staining was done to exclude monocytes from tinuous flow blood cell separator. Table 1 demonstrates the conditioning regimens used for transplantation. Immunothe analysis (all Becton Dickinson, San José, CA, USA). The leukocyte subpopulations were analyzed by forward suppressive therapy post-allo-BMT consisted of cyclospo- AML = acute myeloid leukemia; CML = chronic myeloid leukemia; c-All = common acute lymphoid leukemia; NHL = non-Hodgkin lymphoma; Bu = busulfan; Cy = cyclophosphamide; VP = etoposide; ATG = anti-thymocyte globulin; TBI = total body irradiation; Thio = thiotepa; Mito = mitoxantrone; Ifo = ifosfamide; Ara = arabinoside; Mel = melphalan. . To calculate absolute numbers of the subgroups, the percentage of positive stained cells was multiplied by the absolute count of peripheral blood lymphocytes determined by a Coulter Counter (Hialeah, FL, USA).
Statistical analysis
Results are expressed as mean Ϯ s.e. ϫ 10 6 /l lymphocytes. The Wilcoxon-Mann-Whitney test was used. P-values Ͻ0.05 were considered significant. All P-values are two sided.
Results
Lymphocyte regeneration after PBSCT and allo-BMT was studied within the first 3 months following transplantation. Further subsets of B and T cells were analyzed and compared between the two transplant groups. To determine the maturity or immaturity of the cells in the early period of regeneration, we compared them to the same monoclonal antibody panel on cord-blood cells.
The T lymphocytes (CD3 + CD56 Ϫ CD16 Ϫ cells) recovered faster in the PBSCT group, but kept below normal values during the period studied. Total CD3 + cells at day +100 were 570.87 Ϯ 420.34 (P = 0.07) after allo-BMT, 752.27 Ϯ 384.56 (P = 0.75) after PBSCT, 1382.79 Ϯ 331.02 in normal controls (Figure 1a) . The recovery of the CD4 + cells was markedly delayed during the first 3 months after transplantation, but was faster in the PBSCT group (Figure 1b) , whereas the CD8 + cells regenerated to normal values by day +100 post-transplantation in both groups (Figure 1c) . The faster reconstitution of the CD8 + cell population correlates with the inverse CD4:CD8 ratio following transplantation (Figure 2a ). The total CD3 + lymphocyte count in cord blood (2780.25 Ϯ 278.34) was much higher compared to normal controls, because of the higher absolute CD4 + cell count in cord blood. through a thymus-dependent pathway remained low during the time-period studied in both groups, confirming the reduced capacity for regeneration of immature CD4 + lymthe faster recovery of the total CD4 + cells in the PBSCT group (Figure 3a) . Table 2 demonstrates the absolute numphocytes after transplantation (Figure 3) . The recovery of the mature, antigen responding CD4 + CD45RO + subset, bers of the CD4 + cell subsets at day +100 after transplantation and in cord blood. which recovers thymus-independent, develops faster. We can demonstrate that the regeneration of the CD4 + lymphoThere was a significant difference in both CD4 + populations between PBSCT and allo-BMT after 3 months comcytes is mainly due to the recovery of the mature, memorytype CD4 + CD45RO + cell population. This also explains pared to controls. The CD4 + CD45RA + :CD4 + CD45RO 
CD3
+ count in cord blood compared to normal controls is not different; 64.69 Ϯ 6.02% and 76.64 Ϯ 2.06%, respectively. The absolute T cell count in cord blood is due to the high CD4
+ cell count, reflected by the CD4 + :CD8 + ratio of 2.9 ± 0.24. The CD4 + subsets in cord blood are characterized by a predominance of the immature, naive CD4 The reconstitutional pattern of the CD8 + lymphocyte subsets differs markedly from the CD4 + isoform regeneration. Both CD8 + CD45RA + and CD8 + CD45RO + populations recovered to normal levels by day +100 in both transplanratio was 0.31 ± 0.18 in the PBSCT group and 0.32 ± 0.28 in the allo group at day +100 compared to 0.97 Ϯ 0.17 tation groups. Again, with a faster recovery after PBSCT, reaching normal values of CD8 + CD45RO + cells after 1 in normal controls, reflecting the low regeneration of the immature cell subtype (Figure 2) . The percentage of the month post-transplantation (Figure 5a ). Table 3 shows the 
subsets
There was clearly a faster regeneration of B lymphocytes following PBSCT. They began to reappear at day +20 posttransplant and were at normal levels at day +100; 94.24 Ϯ 37.03 (P = 0.187). The B cells after allo-BMT were not detectable for the first 2 months and were still low at day +100; 34.82 Ϯ 10.45 (P = 0.012). The reference value is 125.26 Ϯ 27.12 ( Figure 6 ). The CD19 + /20 + lymphocytes reappeared as CD38 + , HLA DR + and CD10 Ϫ cells. There was no difference in the pattern of B cell subsets between the PBSCT group and the allo group. The regenerated B lymphocytes resembled those in cord blood. Table 4 shows the percentage of CD19 + /20 + cells at day +100 after PBSCT and in cord blood.
Finally, the NK cells were never absent after transplantation. They were analyzable at day +20 post-transplant already with partially supranormal levels in both groups. At day +100 they were normal in the PBSCT group 183.47 Ϯ 60.50 (P = 0.45) and slighly above normal post-allo-BMT 228.84 Ϯ 81.83 (P = 0.648) compared to 192.62 Ϯ 35.07 in normal controls (Figure 7) .
Discussion
It is known that hematopoietic reconstitution after peripheral blood stem cell transplantation occurs faster than after outcome of reconstitution after myeloablative therapy and Since the absolute number of B cells is increased in cord blood, the percentage has been chosen to demonstrate the equal pattern of distribution. The B lymphocytes at day +100 after allo-BMT were still very low.
reinfusion of collected CD34 + cells. Very recently, it could be shown that CD34
+ subpopulations differ between bone marrow, blood and cord blood. 25 The authors conclude that the proportion of CD34 + cells is higher in bone marrow, but that there is a higher distribution of early myeloid progenitor cells in peripheral blood and cord blood, as compared to more B cell progenitors and later myeloid progenitors in bone marrow. Does a different stem cell source alter the immunological pattern of lymphocyte subset regeneration after PBSCT compared to bone marrow transplantation?
We can demonstrate in this study that, although all subtypes recover faster following PBSCT, there is no difference in the pattern between the two transplant groups. By comparing the early B and T cell subtypes to those sub- not, which has been described for allo-BMT previously, 11, 12 (P = 0.012); PBSCT, 94.24 Ϯ 37.03 (P = 0.187). Reference value also showing that a different stem cell source has no influ-125.26 Ϯ 27.12.
ence on B or T cell subsets. B lymphocytes began to reappear at day +20 after PBSCT in our study, reaching almost normal values after 3 months post-transplantation, whereas B cells remained low following allo-BMT during the study period. These results agree with previous studies.
9,10 Chronic GVHD has been described as a factor that delays B cell reconstitution and influences the B cell subtype.
12,26 B lymphocytes after autologous bone marrow transplantation and after allo-BMT without chronic GVHD express the same antigens as the B cells of healthy neonates, decreasing with age, demonstrating immature B lymphocytes becoming mature after a second round of ontogeny post-transplant. 11 We can show here that development is similar after PBSCT compared to allo-BMT without cGVHD. The B cell type resembles the subset in cord blood. High expression of CD38 + , HLA DR + and a lack of CD10 + antigen demonstrates the immaturity of early B lymphocytes after PBSCT NK cell activity following allo-BMT 27,28 and a normaliznever absent. At day +20 they reached supranormal levels and declined to normal by day +100 post-transplant.
ation of NK cells at day +10 to +20 after PBSCT has been reported. 29, 30 In our study NK cells were present at timeafter PBSCT may partly explain the faster regeneration of B lymphocytes, following PBSCT. The regeneration of naive points of first determination and above normal at day +20, returning to normal values at day +100 in both groups. CD4 + T cells is impaired after allo-BMT and after PBSCT, whereas the recovery of the CD8 + CD45RA + subset is not. In contrast to B lymphocytes, T cells do not repeat ontogeny. The T lymphocytes that reappear after transplanThere seems to be a different maturation pathway for T cell subsets. 
